Prosecution Insights
Last updated: April 19, 2026

Examiner: LYONS, MARY M

Tech Center 1600 • Art Units: 1600 1645 1651 1653

This examiner grants 66% of resolved cases

Performance Statistics

65.6%
Allow Rate
+5.6% vs TC avg
624
Total Applications
+41.6%
Interview Lift
1096
Avg Prosecution Days
Based on 569 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
25.0%
§102 Novelty
22.2%
§103 Obviousness
29.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18014220 METHOD FOR ANTIGEN DETECTION FROM DIRECT CLINICAL SAMPLES Non-Final OA The Regents of the University of California
17786127 DECREASING TOXICITY OF TERPENES AND INCREASING THE PRODUCTION POTENTIAL IN MICRO-ORGANISMS Final Rejection BASF SE
18284680 NEISSERIA GONORRHOEAE DETECTION KIT AND NEISSERIA GONORRHOEAE DETECTION METHOD Non-Final OA ASAHI KASEI KABUSHIKI KAISHA
18344773 PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION Non-Final OA Clara Foods Co.
18014236 MULTISPECIFIC CORONAVIRUS ANTIBODIES Non-Final OA Dana-Farber Cancer Institute, Inc.
19067038 METHODS AND SYSTEMS FOR PHYSICAL EXPANSION AND IMAGING OF BIOLOGICAL SAMPLES Non-Final OA Yale University
17689117 METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY Final Rejection The General Hospital Corporation
18569535 BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BLA36 FOR RELIEVING CONSTIPATION, METHOD FOR CULTURING SAME, AND USE THEREOF Non-Final OA WECARE PROBIOTICS CO., LTD.
18286005 ENCAPSULATED MICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME Non-Final OA Monsanto Technology LLC
18024647 ENGINEERED ORAL BACTERIA AND USES THEREOF Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17673581 COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME Non-Final OA MarvelBiome, Inc.
17908554 PERFORMANCE-ENHANCED PROTEASE VARIANTS VII Final Rejection Henkel AG & Co. KGaA
18273796 BLUE-GREEN ALGAE-CONTAINING TABLET Final Rejection DIC Corporation
17895245 METHODS AND COMPOSITIONS FOR DOCKING BIOTINYLATED ANTIGENS ON THE EXTERIOR OF BACTERIAL OUTER MEMBRANE VESICLES Final Rejection CORNELL UNIVERSITY
17125555 STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF Final Rejection Pfizer Inc.
18265694 COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A LACTOBACILLUS CRISPATUS STRAIN AND/OR OF A COMPOSITION COMPRISING SAME Final Rejection BASF Corporation
18120670 LACTOBACILLUS FORMULATIONS WITH IMPROVED STABILITY AND EFFICACY Non-Final OA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
17540823 BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY Non-Final OA Spogen Biotech Inc.
17310450 METHODS FOR IDENTIFYING MICROBIAL STRAINS HAVING ENHANCED PLANT COLONIZATION EFFICIENCY Non-Final OA NewLeaf Symbiotics, Inc.
17255270 SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM Final Rejection NEWLEAF SYMBIOTICS, INC.
18010677 Means and Methods to Improve Yeast Fermentation Efficiency Non-Final OA KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D
18005204 DUAL FUNCTION SURFACE FOR CELL CAPTURE AND SPREADING Non-Final OA UNIVERSITÉ LAVAL
18548143 TOPICAL COMPOSITION AND USE THEREOF Non-Final OA BLIS TECHNOLOGIES LIMITED
18554108 COMPOSITION FOR INHIBITING BIOFILM COMPRISING LACTOBACILLUS RHAMNOSUS AS ACTIVE INGREDIENT Final Rejection Chr. Hansen A/S
18254961 METHODS AND COMPOSITIONS FOR MICROBIAL TREATMENT OF SKIN DISORDERS Non-Final OA IFF US HOLDING, LLC
18555952 COMPOSITIONS AND METHODS FOR IMPROVING PLANT HEALTH AND CONTROLLING PLANT DISEASE Non-Final OA Certis U.S.A. L.L.C.
18052595 PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES Non-Final OA Conagen Inc.
18285480 NEW YEAST STRAIN AND ITS USES FOR THE CONTROL OF PHYTOPATHOGENS Non-Final OA AGROVENTURES LLC
17791038 Vaccines targeting Neisseria gonorrhoeae Final Rejection Evaxion Biotech A/S
18284587 BACTERIAL STRAINS FOR PREVENTING ESTABLISHMENT AND GROWTH OF HUMAN PATHOGENS ON VEGETABLES Non-Final OA VIVOPROTECT AB

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month